Hubungan Kadar Kreatinin Dengan Hemoglobin Pada Pasien Gagal Ginjal Kronik Sebagai Rujukan Terapi Erythropoietin (EPO)

Authors

  • Thomas Tandi Manu Poltekkes Kemenkes Mataram
  • Trysia Zaena Safitri Poltekkes Kemenkes Mataram
  • Urip Poltekkes Kemenkes Mataram
  • Iswari Poltekkes Kemenkes Mataram
  • Ari Khusuma Poltekkes Kemenkes Mataram

DOI:

https://doi.org/10.47134/inhis.v4i2.132

Keywords:

Kreatinin, Hemoglobin, Erythropoietin

Abstract

Background: Chronic kidney disease (CKD) is a common condition and a global health problem with various causes that lead to a gradual decline in kidney function, resulting in increased creatinine levels. This condition reduces the production of the hormone erythropoietin (EPO), which stimulates the bone marrow to produce red blood cells, leading to decreased hemoglobin levels and resulting in anemia. Erythropoietin (EPO) therapy represents a primary therapeutic option for the management of anemia in patients with chronic kidney disease (CKD) PurposeTo determine the relationship between creatinine and hemoglobin levels in chronic kidney disease patients as a reference for erythropoietin (EPO) therapy. Methods: This study employed an analytical observational method with a cross-sectional approach by reviewing medical record data. The sample consisted of 56 patients obtained through total sampling. The data were analyzed using the Pearson correlation test. Results: The average creatinine level was 9.92 mg/dL, and the average hemoglobin (Hb) level was 7.96 g/dL. Pearson correlation analysis between creatinine and hemoglobin levels in patients receiving erythropoietin (EPO) therapy showed a statistically significant result with a p-value of 0.001 (<0.05) and a moderate negative correlation (r = -0.436). Conclusion: A significant negative correlation was found between creatinine and hemoglobin levels in patients undergoing EPO therapy, indicating that higher creatinine levels tend to be associated with lower hemoglobin concentrations.

References

Abbafati, C., Abbas, K. M., Abbasi, M., Abbasifard, M., Abbasi-Kangevari, M., Abbastabar, H., Abd-Allah, F., Abdelalim, A., Abdollahi, M., Abdollahpour, I., Abedi, A., Abedi, P., Abegaz, K. H., Abolhassani, H., Abosetugn, A. E., Aboyans, V., Abrams, E. M., Abreu, L. G., Abrigo, M. R. M., … Murray, C. J. L. (2020). Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet, 396(10258), 1204–1222. https://doi.org/10.1016/S0140-6736(20)30925-9

Badura, K., Janc, J., W˛asik, J., Gnitecki, S., Skwira, S., Młynarska, E., Rysz, J., & Franczyk, B. (2024). Anemia of Chronic Kidney Disease — A Narrative Review of Its. Biomedicines, 12(6), 1191. https://doi.org/https://doi.org/10.3390/biomedicines12061191

Denic, A., Glassock, R. J., & Rule, A. D. (2016). Structural and Functional Changes With the Aging Kidney. Advances in Chronic Kidney Disease, 23(1), 19–28. https://doi.org/10.1053/j.ackd.2015.08.004

Dewi, N. W. A. M., Yenny, L. G. S., & Cahyawati, P. N. (2023). Hubungan Kadar Kreatinin dan Ureum dengan Derajat Anemia pada Pasien Penyakit Ginjal Kronik di RSUD Sanjiwani Gianyar. Aesculapius Medical Journal, 3(1), 74–80. https://doi.org/10.22225/amj.3.1.2023.74-80

Faizah, R. N., Azizah, N. F., & Purwoko, H. (2022). Perbedaan Efektifitas Terapi Eritropoetin Alfa dan Beta Pada Pasien Hemodialisis Reguler di RSUD Sidoarjo. Majalah Farmaseutik, 18(1), 65. https://doi.org/10.22146/farmaseutik.v18i1.71914

Fujita, Y., Doi, Y., Hamano, T., Hatazaki, M., Umayahara, Y., Isaka, Y., & Tsubakihara, Y. (2019). Low erythropoietin levels predict faster renal function decline in diabetic patients with anemia: a prospective cohort study. Scientific Reports, 9(1), 1–10. https://doi.org/10.1038/s41598-019-51207-8

Inker, L. A., Eneanya, N. D., Coresh, J., Tighiouart, H., Wang, D., Sang, Y., Crews, D. C., Doria, A., Estrella, M. M., Froissart, M., Grams, M. E., Greene, T., Grubb, A., Gudnason, V., Gutiérrez, O. M., Kalil, R., Karger, A. B., Mauer, M., Navis, G., … Levey, A. S. (2021). New Creatinine- and Cystatin C–Based Equations to Estimate GFR without Race. New England Journal of Medicine, 385(19), 1737–1749. https://doi.org/10.1056/nejmoa2102953

KDIGO. (2022). Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. Kidney International, 102(5), S1–S127. https://doi.org/10.1016/j.kint.2022.06.008

KDIGO. (2024). Clinical Practice Guideline For The Evaluation And Management Of Chronic Kidney Disease. International Society of Nephrology, 105(4), 117–314. https://doi.org/10.1046/j.1523-1755.2001.0590051995.x

Lee, S., Kang, S., Lee, Y. S. J. C., Nam, Heon, K., Yun, H.-R., Park, J. T., Chang, T. I., Yoo, T.-H., Kim, S. W., Oh, K.-H., Kim, Y. H., Park, S. K., Kang, S.-W., Choi, K. H., Ahn, C., & Han, S. H. (2021). Smoking, Smoking Cessation, and Progression of Chronic Kidney Disease: Results From KNOW-CKD Study. American Journal of Kidney Diseases, 75(6), 823–832. https://doi.org/https://doi.org/10.1053/j.ajkd.2019.11.011

Levey, A. S., & Coresh, J. (2012). Chronic kidney disease. The Lancet, 379(9811), 165–180. https://doi.org/https://doi.org/10.1016/S0140-6736(11)60178-5

McPherson, R. A., & Pincus, M. R. (2017). Henry’s clinical diagnosis and management by laboratory methods (23rd ed.). Elsevier.

RISKESDAS. (2019). Laporan Riskesdas 2018 Nasional.pdf. In Lembaga Penerbit Balitbangkes. https://repository.badankebijakan.kemkes.go.id/id/eprint/3514/1/Laporan Riskesdas 2018 Nasional.pdf

Setiawan, H., Fitriani, D., Rahmawati, & Itania. (2021). Pengaruh Pemberian Eritropoietin Terhadap Peningkatan Kadar Hemoglobin Pada Pasien Gagal Ginjal Kronik Yang Menjalani Hemodialisa Di Rsud Balaraja. STIKes Widya Dharma Husada Tangerang, 14–29.

Sofyanita, E. N., Afriansya, R., & Palupi, N. I. (2021). Hubungan Kadar Hemoglobin dan Kadar Kreatinin Darah pada Pasien Gagal Ginjal Kronik Pasca Transfusi Berulang. Journal Laboratorium Medis, 02(02), 51–55. https://ejournal.poltekkes-smg.ac.id/ojs/index.php/JLM/

Stauffer, M. E., & Fan, T. (2014). Prevalence of anemia in chronic kidney disease in the United States. PLoS One, 9(1). https://doi.org/https://doi.org/10.1371/journal.pone.0084943

Syahputra, A., Abdurrahman, A., & Mutiah, C. (2022). Perbandingan Kadar Hemoglobin Sebelum Dan Sesudah Hemodialisa Pada Pasien Gagal Ginjal Kronis. Malahayati Nursing Journal, 4(7), 1749–1756. https://doi.org/10.33024/mnj.v4i7.6546

WHO. (2025). Reducing the burden of noncommunicable diseases through promotion of kidney health and strengthening prevention and control of kidney disease. In Agenda item 13.2 (Vol. 10, Issue May). https://apps.who.int/iris/handle/10665/332070,

Wiradharma, K. G., Suwitra, K., Raka Widiana, I. G., Sudhana, I. W., Loekman, J. S., Kandarini, Y., & Paramita Ayu, N. (2016). Korelasi antara kadar hemoglobin dan fungsi kognitif pada penyandang hemodialisis regular di Rumah Sakit Umum Pusat Sanglah Denpasar. Medicina, 47(3), 49–53. https://doi.org/10.15562/medicina.v47i3.94

Downloads

Published

2025-08-31

How to Cite

Tandi Manu, T., Zaena Safitri, T., Urip, U., Pauzi, I., & Khusuma, A. (2025). Hubungan Kadar Kreatinin Dengan Hemoglobin Pada Pasien Gagal Ginjal Kronik Sebagai Rujukan Terapi Erythropoietin (EPO). Indonesian Health Issue, 4(2), 144–151. https://doi.org/10.47134/inhis.v4i2.132

Issue

Vol. 4 No. 2 (2025): AGUSTUS

Section

Articles

License

Copyright (c) 2025 Indonesian Health Issue

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.